| Identification | Back Directory | [Name]
6-(3,3,5-trimethyl-7-azabicyclo[3.2.1]octan-7-yl)-7H-purine | [CAS]
924764-38-5 | [Synonyms]
NPD7155
NPD-7155
NPD 7155
6-(3,3,5-trimethyl-7-azabicyclo[3.2.1]octan-7-yl)-7H-purine
6-Azabicyclo[3.2.1]octane, 1,3,3-trimethyl-6-(9H-purin-6-yl)- | [Molecular Formula]
C15H21N5 | [MOL File]
924764-38-5.mol | [Molecular Weight]
271.36 |
| Hazard Information | Back Directory | [Description]
NPD7155 is a competitive MTH1 inhibitor. | [Uses]
NPD7155 is a purine-based competitive inhibitor of MTH1, designed to target cancer cells while exhibiting off-target effects that contribute to its cytotoxicity. | [References]
[1] Proteomic profiling of small-molecule inhibitors reveals dispensability of MTH1 for cancer cell survival DOI:10.1038/srep26521 |
|
| Company Name: |
PHARMEKS Ltd.
|
| Tel: |
+7 (495) 702-9648 |
| Website: |
www.pharmeks.com |
|